Antitumor activity of DTIC (NSC-45388) in animals.
D000818:Animals; D002460:Cell Line; D003606:Dacarbazine / Q000627:therapeutic use* / Q000633:toxicity; D004317:Doxorubicin / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D004359:Drug Therapy, Combination; D007928:Lethal Dose 50; D007939:Leukemia L1210 / Q000188:drug therapy; D007942:Leukemia, Experimental / Q000188:drug therapy*; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D051381:Rats; D014226:Triazenes / Q000627:therapeutic use*
D014226:Triazenes; D003606:Dacarbazine; D004317:Doxorubicin